Phathom Pharmaceuticals, Inc. PHAT Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s debt repayments?
- Phathom Pharmaceuticals, Inc. (PHAT) reported debt repayments of $229.05M in Q1 2026.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.